AgeX Therapeutics, Inc. Note Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sixth Amendment to Amended and Restated Convertible Promissory Note, dated February 9, 2024, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Eighth Amendment to Amended and Restated Convertible Promissory Note dated May 8, 2024, between UniverXome Bioengineering, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Agreement with respect to Convertible Notes dated March 26, 2024, among AgeX Therapeutics, Inc., UniverXome Bioengineering, Inc., the Subsidiary Obligors and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Allonge and Seventh Amendment to Amended and Restated Convertible Promissory Notes dated March 26, 2024, among AgeX Therapeutics, Inc., the Guarantors party thereto and...
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amendment to Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Fourth Amendment to Amended and Restated Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to Amended and Restated Secured Convertible Promissory Note, dated June 2, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Allonge and Second Amendment to Amended and Restated Convertible Promissory Note dated May 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Convertible Promissory Note, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Convertible Note Purchase Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Secured Convertible Promissory Note dated March 13, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amended and Restated Secured Convertible Promissory Note, dated February 9, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Secured Note dated February 14, 2022, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2022